Stock events for Acme United Corp. (ACU)
Acme United Corp.'s stock has been affected by its Q1 2026 financial results and strategic acquisitions. Q1 2026 net sales increased by 14% to $52.3 million, but net income declined by 40% to $1.0 million, with EPS falling by 41% to $0.24, missing analyst expectations due to higher costs and expenses. The stock reacted negatively to the earnings report. The acquisition of My Medic contributed to sales growth, with minimal impact on Q1 earnings due to seasonality. The acquisition of a German cutting and sharpening product line in October 2025 contributed to European sales growth. A quarterly dividend of $0.16 per share was declared in March 2026.
Demand Seasonality affecting Acme United Corp.’s stock price
Demand for Acme United Corp.'s products exhibits seasonality, with the first quarter typically experiencing lower sales. The My Medic business is also seasonal, with most of its profitability generated in the fourth quarter.
Overview of Acme United Corp.’s business
Acme United Corp. operates in the Consumer Defensive sector, supplying cutting, measuring, first aid, and sharpening products globally. Its products cater to schools, homes, offices, hardware, sporting goods, and industrial sectors. The company's main brands include Westcott, Clauss, PhysiciansCare, and First Aid Only. Founded in 1867, it was incorporated in 1873.
ACU’s Geographic footprint
Acme United Corp. has a global presence with operations in the United States, Canada, Europe (Germany), and Asia (Hong Kong and China). The majority of its revenue comes from the United States. Operations in the U.S., Canada, and Europe focus on product development, manufacturing, marketing, sales, administration, and distribution, while Asian operations handle sourcing, quality control, and sales.
ACU Corporate Image Assessment
There have been no specific events that significantly impacted Acme United Corp.'s brand reputation positively or negatively in the past year. The company maintains a long-standing presence in its markets, focusing on innovative products. Its European team showcased medical products at Medica 2025, indicating efforts to strengthen its presence in the medical sector.
Ownership
Acme United Corp.'s ownership is distributed among institutional investors, insiders, and public/individual investors. Institutional investors hold a significant portion of shares, with reports indicating around 51.50% or 69.00% held by institutions. Major institutional holders include Capital Management Corp and Vanguard Group Inc. Insiders, including CEO Walter C. Johnsen, possess a notable percentage of shares. R. Scott Asen is a significant individual shareholder.
Ask Our Expert AI Analyst
Price Chart
$42.16